Endothelial progenitor cells (CD34(+)KDR(+)) and monocytes may provide the development of good coronary collaterals despite the vascular risk factors and extensive atherosclerosis


Kocaman S. A. , YALÇIN M. R. , Yagci M., ŞAHİNARSLAN A., TÜRKOĞLU S., Arslan U., ...More

ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY, vol.11, no.4, pp.290-299, 2011 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 11 Issue: 4
  • Publication Date: 2011
  • Doi Number: 10.5152/akd.2011.078
  • Journal Name: ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY
  • Journal Indexes: Science Citation Index Expanded, Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.290-299
  • Keywords: Endothelial progenitor cell, monocyte, collateral development, atherosclerosis, CD34, vascular endothelial growth factor 2, logistic regression analysis, ARTERY-DISEASE, DIABETES-MELLITUS, OCCLUSION, GROWTH, TRANSPLANTATION, ATHEROGENESIS, ANGIOGENESIS, VESSELS, INJURY

Abstract

Objective: Endothelial progenitor cells (EPC) have a regenerative role in the vascular system. In this study, we aimed to evaluate simultaneously the effects of EPC and inflammatory cells on the presence and the extent of coronary artery disease (CAD) and the grade of coronary collateral growth in patients with clinical suspicion of CAD.